Cleveland Clinic

Cleveland Clinic Ventures serves as the strategic venture capital arm of the Cleveland Clinic, a globally recognized non-profit academic medical center. Established in 2015, its primary mission is to accelerate the commercialization of innovative healthcare technologies, both those developed internally within the Clinic and those from external promising startups. The fund focuses on investments that align with Cleveland Clinic's clinical priorities, aiming to improve patient care and outcomes through groundbreaking solutions.

The investment strategy of Cleveland Clinic Ventures is characterized by its strategic, value-add approach. They typically co-invest alongside traditional venture capital firms, participating in early to growth-stage rounds, including Seed, Series A, and Series B. Beyond capital, Cleveland Clinic Ventures offers its portfolio companies unparalleled access to the Clinic's extensive clinical expertise, research infrastructure, and vast network of physicians and patients. This unique value proposition helps de-risk and accelerate the development of medical devices, digital health platforms, diagnostics, and therapeutics.

Since its inception, Cleveland Clinic Ventures has demonstrated a robust investment pace. By 2019, the fund had reportedly deployed approximately $40 million across 18 companies, underscoring its commitment to fostering innovation in the healthcare sector. More recently, their portfolio has expanded significantly, now comprising over 30 companies that are actively developing and commercializing advanced medical technologies. These investments are instrumental in translating scientific discoveries into tangible products and services that address critical unmet needs in healthcare.